Skip to main content
. 2015 Mar 15;13:111. doi: 10.1186/s12957-015-0505-x

Figure 3.

Figure 3

MicroPET-CT imaging of A431 tumors before and after gefitinib treatment. (A) Gefitinib-sensitive tumors on day 2, 7, and 14. (B) Gefitinib-stable tumors on day 2, 7, and 14. (C) Tumors in the control group on day 2, 7, and 14. White arrow indicates tumor.